USA's Biogen Idec, one of the world's largest biotech companies, has inaugurated its packaging facility in Hillerød, north of Copenhagen, where the company is constructing its European manufacturing plant. Biogen Idec's facility for drug production is under construction and is expected to be completed in 2010. When the entire manufacturing plant is finished, the US company will have invested USD 500 m.
Paul Coleman, managing director of Biogec Idec in Denmark says: "The packaging facility is now in operation and supplying drugs for countries throughout the world."
The packaging, labelling and distribution of Biogen Idec's drugs for the world market has been carried out for 10 years in the Dutch city of Hoofddorp, but this facility was closed on 29 June, and the associated planning, logistics and distribution functions are now being carried out in Hillerød. The laboratory handling quality control has also been moved to Hillerød. The new facility in Denmark supplies Biogen Idec drugs for the world market except the US and Canada, which are being supplied from the US.
The story of Biogen and the town of Hillerød started in 2000, when the biotech company planned to establish a large-scale manufacturing plant in Europe. Looking at various opportunities for where to place the plant, the choice came down to two locations, either in Ireland or Denmark.
"I am Irish, so it was an interesting exercise for me to be part of taking that decision. But after many months of thorough analysis, we chose Denmark, and regardless of whether you are Irish, Danish or American, there is no doubt that it was the right business decision. I also think the last seven years have showed this to be true," says Paul Coleman.
Biogen Idec is currently employing 205 people in Hillerød, a figure which is expected to grow to approx. 250 before the end of this year. When the production plant is completed, the company will employ 400 people at its Danish manufacturing and packaging facility.
The news was reported by Pharnia.